Profile | GDS4284 / 236475_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 172.514 | 47 |
GSM687648 | Patient 402 control | 392.296 | 60 |
GSM687653 | Patient 403 control | 22.0014 | 14 |
GSM687658 | Patient 404 control | 220.469 | 50 |
GSM687663 | Patient 411 control | 356.979 | 58 |
GSM687668 | Patient 422 control | 276.337 | 54 |
GSM687673 | Patient 424 control | 225.475 | 49 |
GSM687678 | Patient 425 control | 307.687 | 55 |
GSM687683 | Patient 427 control | 222.911 | 48 |
GSM687688 | Patient 428 control | 155.561 | 43 |
GSM687695 | Patient 441 control | 2334.47 | 87 |
GSM687699 | Patient 443 control | 540.082 | 64 |
GSM687704 | Patient 444 control | 167.66 | 45 |
GSM687707 | Patient 448 control | 26.9473 | 13 |
GSM687712 | Patient 449 control | 75.7729 | 29 |
GSM687719 | Patient 450 control | 157.609 | 40 |
GSM687724 | Patient 451 control | 181.586 | 44 |
GSM687728 | Patient 452 control | 1078.84 | 76 |
GSM687646 | Patient 401 treated 24h | 152.437 | 43 |
GSM687649 | Patient 402 treated 24h | 263.199 | 54 |
GSM687665 | Patient 411 treated 24h | 437.148 | 61 |
GSM687651 | Patient 402 treated 4 weeks | 327.045 | 56 |
GSM687667 | Patient 411 treated 4 weeks | 322.315 | 56 |
GSM687670 | Patient 422 treated 24h | 255.023 | 52 |
GSM687671 | Patient 422 treated 4 weeks | 129.156 | 40 |
GSM687654 | Patient 403 treated 24h | 73.3978 | 31 |
GSM687675 | Patient 424 treated 24h | 179.573 | 44 |
GSM687685 | Patient 427 treated 24h | 244.064 | 52 |
GSM687656 | Patient 403 treated 4 weeks | 82.8149 | 33 |
GSM687677 | Patient 424 treated 4 weeks | 192.037 | 48 |
GSM687687 | Patient 427 treated 4 weeks | 98.8333 | 36 |
GSM687692 | Patient 428 treated 4h | 241.737 | 52 |
GSM687716 | Patient 449 treated 4h | 181.715 | 47 |
GSM687722 | Patient 450 treated 4h | 274.18 | 52 |
GSM687680 | Patient 425 treated 24h | 243.603 | 52 |
GSM687690 | Patient 428 treated 24h | 235.068 | 52 |
GSM687700 | Patient 443 treated 24h | 776.8 | 69 |
GSM687705 | Patient 444 treated 24h | 172.694 | 47 |
GSM687714 | Patient 449 treated 24h | 122.248 | 40 |
GSM687721 | Patient 450 treated 24h | 500.654 | 62 |
GSM687682 | Patient 425 treated 4 weeks | 298.763 | 56 |
GSM687694 | Patient 428 treated 4 weeks | 280.19 | 55 |
GSM687702 | Patient 443 treated 4 weeks | 291.527 | 53 |
GSM687718 | Patient 449 treated 4 weeks | 137.383 | 40 |
GSM687723 | Patient 450 treated 4 weeks | 232.51 | 50 |
GSM687661 | Patient 404 treated 4h | 127.596 | 38 |
GSM687710 | Patient 448 treated 4h | 137.166 | 41 |
GSM687726 | Patient 451 treated 4h | 213.351 | 47 |
GSM687730 | Patient 452 treated 4h | 1098.98 | 76 |
GSM687660 | Patient 404 treated 24h | 544.562 | 66 |
GSM687697 | Patient 441 treated 24h | 2040.58 | 85 |
GSM687709 | Patient 448 treated 24h | 81.6669 | 29 |
GSM687725 | Patient 451 treated 24h | 226.24 | 47 |
GSM687729 | Patient 452 treated 24h | 1206.12 | 79 |
GSM687727 | Patient 451 treated 4 weeks | 246.717 | 50 |
GSM687731 | Patient 452 treated 4 weeks | 814.393 | 71 |